Vaccine Study for Surgically Resected Pancreatic Cancer

Recruiting in Palo Alto (17 mi)

+17 other locations

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Phase 2

Waitlist Available

Sponsor: NewLink Genetics Corporation

No Placebo Group

Prior Safety Data

Trial Summary

What is the purpose of this trial?

To assess the response for subjects with pancreatic cancer that have undergone surgical resection and treatment with a vaccine given with chemotherapy and chemoradiation.

Eligibility Criteria

Inclusion Criteria

A histological diagnosis of adenocarcinoma of the pancreas.

AJCC Stage I or II Pancreatic carcinoma (See Appendix A). Patients must have undergone surgical resection for the tumor and extent of resection must be either R0 (complete resection with grossly and microscopically negative margins of resection) or R1 (grossly negative but positive microscopically margins of resection).

Eastern Cooperative Oncology Group (ECOG) Performance Status ≤ 2.

See 7 more